Understanding and Targeting Apoptotic Pathways in Ovarian Cancer
Ovarian cancer cells evade the immune system as well as chemotherapeutic and/or biologic treatments through inherent or acquired mechanisms of survival and drug resistance. Depending on the cell type and the stimuli, this threshold can range from external forces such as blunt trauma to programmed pr...
Main Authors: | Linah F. Al-Alem, Andrew T. Baker, Unnati M. Pandya, Eric L. Eisenhauer, Bo R. Rueda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/11/1631 |
Similar Items
-
Equol induces apoptosis in chemoresistant ovarian cancer cells via external pathway
by: Xue-Mei Gong, et al.
Published: (2015-12-01) -
Galectins and Ovarian Cancer
by: Chisa Shimada, et al.
Published: (2020-05-01) -
CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
by: Xiaojie Feng, et al.
Published: (2019-06-01) -
Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
by: Sandra Muñoz-Galván, et al.
Published: (2021-08-01) -
Mechanisms Involved in Chemoresistance in Ovarian Cancer
by: Kar-San Ling, et al.
Published: (2005-09-01)